Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Google-backed AI-developed drugs are headed to trial by 2026, says DeepMind CEO )
Also on site :
- Bitcoin data suggests possible 62% price surge
- Beyond the Game: Haier Vision for Youth and Sustainability
- Bitcoin data hints at potential 62% price increase